The results showed that MYL9 expression levels significantly correlated with the most significant marker genes of various immune cells in colon and rectal cancers, including M2 macrophages, tumor-associated macrophages (TAMs), and dendritic cells (Supplementary file 1: Table 6). Here, MYL9 is linked to neoplasm.